Guardant360® CDx Cancer Test

4.8/5
Guardant360 CDx is a liquid biopsy for people with advanced solid cancer: a blood test that analyses tumour DNA in your bloodstream across 74 cancer genes to identify mutations that may respond to targeted therapies or clinical trials, without a tissue biopsy. From £2,469, following a consultation with our consultant oncologist to confirm it is right for you. Results in 7 working days, reviewed with you by the oncologist afterwards.... Read more

Guardant360 CDx is a liquid biopsy for people with advanced solid cancer: a blood test that analyses tumour DNA in your bloodstream across 74 cancer genes to identify mutations that may respond to targeted therapies or clinical trials, without a tissue biopsy. From £2,469, following a consultation with our consultant oncologist to confirm it is right for you. Results in 7 working days, reviewed with you by the oncologist afterwards.

Key facts

  • Price: from £2,469 with your own sample collection; £2,499 at a Goodbody clinic; £2,529 with a nurse home visit. A 30-minute oncologist consultation (£149) is required first and is refunded against the test if you go ahead
  • Analyses: circulating tumour DNA across 74 genes for mutations, fusions and amplifications linked to approved targeted treatments
  • For: adults with a diagnosed advanced solid cancer (stage III or IV) whose cancer has progressed on treatment or whose tissue testing was incomplete or inconclusive; off treatment for at least 10 days
  • Not for: blood cancers (leukaemia, lymphoma, myeloma) or early-stage (I or II) cancers
  • Sample: two tubes of venous blood; no tissue biopsy, no radiation, no hospital stay
  • Results: within 7 working days of the sample reaching the laboratory, reviewed with you by our consultant oncologist

Your questions answered

What is Guardant360?

Guardant360 CDx is a comprehensive genomic profiling test performed on a blood sample rather than a piece of tumour. Cancers shed fragments of their DNA into the bloodstream; the test captures this circulating tumour DNA and sequences 74 genes to find the specific mutations driving the cancer. Some of those mutations have approved targeted drugs or immunotherapies that work against them, and others point to clinical trials. It is approved by the US FDA as a companion diagnostic and is used in the NHS for lung cancer. The result is a report your oncologist can use to choose or change treatment.

Who is Guardant360 CDx for?

People with a confirmed diagnosis of advanced solid cancer, stage III or IV, in situations where knowing the tumour's genetic profile could change treatment: the cancer has progressed on the current therapy, no tissue sample is available or a biopsy is not safe, or tissue testing came back incomplete or inconclusive. You need to have been off treatment for at least 10 days so that enough tumour DNA is circulating. It is not suitable for blood cancers or for early-stage disease, and it is not a screening test for people without a diagnosis.

Is Guardant360 available in the UK, and can I get it on the NHS?

Yes, it is available privately through Goodbody Clinic across the UK. The NHS uses Guardant360 for some patients with advanced non-small cell lung cancer, where tissue is unavailable, through the Genomic Medicine Service; for other cancers access is limited. If your oncologist has recommended comprehensive genomic profiling and it is not available to you, or waiting for it would delay treatment decisions, private testing is a way to get the same report within about two weeks of booking.

How much does a Guardant360 test cost in the UK?

From £2,469 with your own blood collection, £2,499 at a Goodbody clinic or £2,529 with a nurse home visit. The required consultant oncologist consultation is £149 and is refunded against the test if you proceed, so the consultation costs nothing if the test goes ahead. The price includes sequencing of all 74 genes, the clinical report and a results consultation with the oncologist. We also offer Guardant360 Liquid, a 740-gene panel with epigenomic analysis, from £4,320.

Why is an oncologist consultation required first?

Because the test is only useful in specific circumstances, and the report is only useful if someone can act on it. Our consultant oncologist reviews your diagnosis, stage, previous tissue results and treatment history to confirm the test could change your options, checks you have been off treatment long enough for a reliable result, and advises whether Guardant360 CDx or the larger Guardant360 Liquid panel is the right choice. The consultation is a 30-minute telephone call, does not replace your own oncologist, and is refunded if you go ahead with the test.

How does a liquid biopsy compare with a tissue biopsy?

A tissue biopsy examines a sample from one site of the tumour, needs a procedure that may involve anaesthetic, radiation guidance or surgery, and can take weeks. A liquid biopsy needs two tubes of blood, carries no procedural risk, reflects DNA shed from all tumour sites, and reports within a week. Its limitation is that some tumours shed little DNA, in which case the result may not detect mutations that are present; in those cases a tissue test may still be needed, and the report says so. The two are complementary, and oncologists increasingly use blood first.

What does the Guardant360 report show?

A list of the genomic alterations detected in your tumour DNA, mutations, fusions, amplifications and, where relevant, markers such as microsatellite instability, matched to approved targeted therapies and immunotherapies for your cancer type and to relevant clinical trials. It also reports the fraction of tumour DNA found, which indicates how much confidence to place in a negative result. Our oncologist walks you through the report and prepares a summary for your treating team.

How long does the process take?

Book the oncologist consultation, usually available within days. If the test is suitable, book your blood draw at one of 250+ clinics or with a nurse at home. Results are returned within 7 working days of the sample reaching the laboratory, and your results consultation is booked as soon as they arrive. Most people have a report in hand within two to three weeks of first contact.

Will my own oncologist accept the results?

Guardant360 CDx is the same test used in NHS and international practice and its reports are written for oncologists, so your treating team can act on them directly. Our oncologist provides a summary letter to accompany the report. Decisions about changing treatment remain with the team treating you.

Does Guardant360 detect all cancers, or tell me if I have cancer?

No. It is not a screening test and should not be used by anyone without a confirmed cancer diagnosis; for screening, see our TruCheck test. It profiles the DNA of a known solid tumour to guide treatment. It does not cover blood cancers.

What if no actionable mutation is found?

Around one in three profiles finds no alteration with an approved matched therapy. That is still useful: it rules options out, may identify trials, and tells your team that standard treatment remains the best path. If the tumour DNA fraction was very low, the oncologist will explain whether a repeat or a tissue test is worthwhile.

Where can I have the blood taken?

At any of 250+ Goodbody clinics across the UK, by a nurse at home, or by a professional you arrange using the kit we send you. No fasting is needed and the draw takes a few minutes. Find your nearest clinic.

What happens next

Your results are emailed within the stated turnaround of your sample reaching the laboratory, and are reviewed with you by our consultant oncologist, who explains what the findings mean and sets out the options to discuss with your treating team. Your report is written for oncologists and can be shared with your own specialist. All samples are analysed by an accredited laboratory.

Read less
  • Venous Sample
  • Oncologist Supported
  • Therapy Guidance
  • 250+ Clinic Locations
  • Results in 7 Working Days
Check Availability (Based on location)
  • Clearpay
  • Splitit
  • Visa
  • Mastercard
  • Apple Pay
  • Shop Pay
  • Google Pay
More Information

The test can be performed as advised by the Oncologist, without the cost and risks involved with radiation from scans, hospitalisation, anaesthesia or painful surgical biopsies.

Benefits:

  • Get peace of mind & monitor your solid cancer diagnosis
  • Make informed treatment decisions for patients who have progressed on therapy
  • No waiting lists
  • Consultation with Oncologist to advise on the test (not to take on your primary oncologist care).

 

Who can take the Guardant360 CDx blood test?

Individuals who have been diagnosed with advanced solid cancer (stage III/IV) whereby the cancer is not progressing on the current treatment or current tumour testing is incomplete or inconclusive.

Patient must have been off treatment for a minimum of 10 days.

Not suitable for individuals with:

  • Hematologic malignancies (Blood / lymph nodes / bone)
  • Early stage (stage I/II) cancers

 

How does the process work?

  1. Book and pay for a consultation with our Oncologist to ensure suitability and determine this test is right for you.
  2. If suitable, book your Guardant360 CDx test – in clinic or at home with a nurse visit.
  3. Attend your appointment.
  4. Receive your results within 7 working days of the sample reaching the lab.

 

How does the Guardant360 CDx test work?

Guardant360 CDx is a simple blood test which analyses 74 genes within your existing solid cancer tumour DNA, to provide cancer genomic alterations detected in your blood.

Some genomic alterations may mean you are more likely to respond to certain drugs, or, indicate your cancer could be resistant to treatment. An oncologist will interpret results to inform the best treatment for you.

The report will highlight current approved drugs available and drugs currently available on clinical trial.

Traditionally, the only way to analyse genomic changes in your cancer was through tissue biopsies. The Guardant360 CDx test can provide the same information from a simple blood draw.

How often should I test?

Testing frequency depends on your condition – the Oncologist will advise a test schedule that works best for you.

When will I get my results?

The results are typically returned to you via email within 7 working days of reaching the lab.

Not sure if this test
is right for you?

Enquire via the form and a member of our team will get back to you, they are more than happy to help answer your questions and talk through the best option for you.

Contact us if you aren't sure, we'd be happy to help!

Register Your Interest

FAQs

PLACING AN ORDER

How does the service work?

Who will take my blood draw?

Who sends off my sample?

How do I book?

Can I book the blood draw for someone else?

Can I eat or drink before my blood draw?

My sample needs centrifuging

We promise to deliver affordable testing to everybody.

When you’re worried about your health, life can feel very stressful, especially if you don’t have the answers you need. We believe that health testing should be available to all, giving you answers when and where you need them.

That’s why we’ve partnered with Splitit, Dopple and Clearpay so you can pay for your tests in interest-free instalments, if you prefer.